WhichRecall
Class IIReported 2026-01-07

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Recalled by Novo Nordisk Inc.

Reason for Recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Advertisement
Recall Number
D-0245-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-12-19
Reported
2026-01-07
Distribution
Nationwide within the United States.
Code Info
Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement